MEI Pharma Inc./$LITS
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About MEI Pharma Inc.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Ticker
$LITS
Sector
Primary listing
Employees
4
Headquarters
Website
MEI Pharma Inc. Metrics
BasicAdvanced
$71M
-
-$0.94
0.05
-
Price and volume
Market cap
$71M
Beta
0.05
52-week high
$9.00
52-week low
$1.46
Average daily volume
612K
Financial strength
Current ratio
12.393
Quick ratio
9.469
Profitability
EBITDA (TTM)
-15.119
Management effectiveness
Return on assets (TTM)
-13.48%
Return on equity (TTM)
-16.88%
Valuation
Price to book
1.22
Price to tangible book (TTM)
1.22
Price to free cash flow (TTM)
-1.708
Free cash flow yield (TTM)
-58.55%
Free cash flow per share (TTM)
-1.124
Growth
Earnings per share change (TTM)
-86.61%
3-year earnings per share growth (CAGR)
-53.15%
10-year earnings per share growth (CAGR)
-25.62%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MEI Pharma Inc. stock?
MEI Pharma Inc. (LITS) has a market cap of $71M as of November 27, 2025.
What is the P/E ratio for MEI Pharma Inc. stock?
The price to earnings (P/E) ratio for MEI Pharma Inc. (LITS) stock is 0 as of November 27, 2025.
Does MEI Pharma Inc. stock pay dividends?
No, MEI Pharma Inc. (LITS) stock does not pay dividends to its shareholders as of November 27, 2025.
When is the next MEI Pharma Inc. dividend payment date?
MEI Pharma Inc. (LITS) stock does not pay dividends to its shareholders.
What is the beta indicator for MEI Pharma Inc.?
MEI Pharma Inc. (LITS) has a beta rating of 0.05. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.